文献速递关节外科

淋巴水肿是全髋关节置换术后失败的重要危险因素

Lymphedema Is a Significant Risk Factor for Failure After Primary Total Hip Arthroplasty.
PubMed 文献 · J Bone Joint Surg Am · 2022-01-01

回顾性匹配队列研究比较83例伴淋巴水肿与498例无淋巴水肿的原发全髋关节置换患者,平均随访6年;淋巴水肿组并发症、再手术和感染风险均显著升高,5年无感染生存率90.3%对97.7%。

要点

  • 淋巴水肿患者原发全髋置换后并发症风险约为无淋巴水肿者的1.97倍。
  • 再手术风险HR 3.16、感染风险HR 4.48,均具统计学意义。
  • 5年无感染生存率淋巴水肿组90.3%,对照组97.7%。

核心结论

  • 淋巴水肿患者原发全髋关节置换后并发症、再手术和感染风险均显著增加。

研究设计与样本

  • 回顾性队列研究,利用机构全关节登记和病历识别83例伴同侧淋巴水肿行全髋置换患者,按性别、年龄、手术日期和BMI 1:6匹配498例无淋巴水肿的骨关节炎全髋置换患者,平均随访6年。

主要发现

  • 淋巴水肿组并发症风险HR 1.97(p<0.01),任何原因再手术HR 3.16(p<0.01),术后感染HR 4.48(p<0.01)。
  • 5年无感染生存率淋巴水肿组90.3%,无淋巴水肿组97.7%(p<0.01)。

临床怎么用

  • 术前应针对淋巴水肿患者进行充分咨询,告知再手术和感染风险升高。
  • 可考虑术前优化淋巴水肿及改进围手术期管理以改善结局。

局限性

  • 证据等级为预后Level III,属回顾性研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Lymphedema is a chronic disease characterized by fluid buildup and swelling that can lead to skin and soft-tissue fibrosis and recurring soft-tissue infections. Literature with regard to the increased risk of complications following a surgical procedure in patients with lymphedema is emerging, but the impact of lymphedema in the setting of primary total hip arthroplasty (THA) remains unknown. The purpose of this study was to review outcomes following primary THA performed in patients with lymphedema compared with a matched cohort without lymphedema. METHODS: Using our institutional total joint registry and medical records, we identified 83 patients (57 were female and 26 were male) who underwent THA with ipsilateral lymphedema. For comparison, these patients were matched 1:6 (based on sex, age, date of the surgical procedure, and body mass index [BMI]) to a group of 498 patients without lymphedema who underwent primary THA for osteoarthritis. Subsequently, postoperative complications and implant survivorship were evaluated for each group. The mean follow-up for each group was 6 years. Survivorship was compared between cohorts using Kaplan-Meier methodology and included both survivorship free of infection and survivorship free of reoperation or revision. Univariate Cox regression analysis was utilized to assess the association between patient factors for the time to event outcomes noted above. RESULTS: In patients with a history of lymphedema, there was an increased risk of complications (hazard ratio [HR], 1.97; p < 0.01), including reoperation for any cause (HR, 3.16; p < 0.01) and postoperative infection (HR, 4.48; p < 0.01). The 5-year infection-free survival rate was 90.3% for patients with lymphedema compared with 97.7% for patients without lymphedema (p < 0.01). CONCLUSIONS: Patients with lymphedema are at increased risk for complications, including reoperation and infection, following primary THA. These data emphasize the importance of appropriate preoperative counseling in this population and should encourage efforts to identify methods to improve outcomes, including further investigation of the effects of preoperative optimization of lymphedema prior to THA and methods for improved perioperative management. LEVEL OF EVIDENCE: Prognostic Level III. See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Rainer WG, Kolz JM, Wyles CC, et al. Lymphedema Is a Significant Risk Factor for Failure After Primary Total Hip Arthroplasty. J Bone Joint Surg Am. 2022. PMID: 34637411. doi:10.2106/JBJS.20.01970

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。